Targeted retrograde gene delivery to motor neurons
View Patent ↗Methods are disclosed for delivering a heterologous gene to a cell body of a neuron by contacting a muscle tissue innervated by the neuron with a viral vector comprising a heterologous gene, wherein the viral vector enters said neuron and is retrogradely moved to the cell body. Additionally, methods for expressing secreted proteins from a nerve cell body as well as methods for treating neurodegenerative disorders such as amyotrophic lateral sclerosis are described.
1. A method for delivering a heterologous gene to a cell body of a neuron, comprising:
contacting a muscle tissue innervated by said neuron with an AAV viral vector comprising a heterologous gene, wherein said AAV viral vector enters said neuron and is retrogradely moved to the cell body.
2. The method of claim 1 , wherein said AAV viral vector exhibits tropism toward neurons.
3. The method of claim 1 , wherein said neuron is a motor neuron.
4. The method of claim 1 , wherein at least 1.5×10 7 infectious particles of said AAV viral vector are provided.
5. The method of claim 1 , wherein at least 1.5×10 8 infectious particles of said AAV viral vector are provided.
6. The method of claim 1 , wherein at least 1.5×10 9 infectious particles of said AAV viral vector are provided.
7. The method of claim 1 , wherein said heterologous gene is stably integrated.
8. The method of claim 1 , wherein said gene is expressed.
9. The method of claim 8 , wherein said gene is expressed by said neuron for at least two months.
10. The method of claim 8 , wherein said gene is expressed by said neuron for at least four months.
11. A method for expressing a protein that is secreted from a target neuron, said method comprising:
contacting a muscle tissue innervated by said neuron with an AAV viral vector comprising a heterologous gene encoding said protein, wherein said AAV viral vector enters said neuron and is retrogradely moved to the cell body where said gene is expressed.
12. The method of claim 11 , wherein the expression of said secreted protein is constitutive.
13. The method of claim 11 , wherein the expression of said secreted protein is regulatable.